Abstract
With recent development in molecular biology, reverse transcriptase polymerase chain reaction (RT-PCR) has been applied to detect occult lymph node metastasis, but there have been few reports concerning oesophageal cancer. The objective of this study is to investigate the usefulness of the squamous cell carcinoma (SCC) antigen gene as a marker with RT-nested PCR to detect occult lymph node metastases of oesophageal cancer. The SCC antigen has been widely used as a serum tumour marker and was reported as a target gene to detect tumour cells in peripheral blood in cervical cancer. In this study, 620 lymph nodes from 14 oesophageal cancer patients were analysed. The results of RT-nested PCR were compared with that of pathological and immunohistochemical examinations. In the test of sensitivity, the RT-nested PCR detected 101 of SCC antigen producing cells in 107 peripheral blood mononucleocytes and was not found in 43 control lymph nodes. The pathological examination, immunohistochemical examination and the RT-nested PCR detected 36, 45 and 65 nodes respectively. The RT-nested PCR detected statistically more lymph nodes than the pathological or immunohistochemical examination. The sensitivity and specificity seem higher in squamous cell carcinoma cases. The SCC antigen gene is one of the more useful markers for RT-nested PCR to detect occult lymph node metastases of oesophageal cancer. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Abe S, Tachibana M, Shiraishi M and Nakamura T (1990) Lymph node metastasis in resectable esophageal cancer [see comments]. J Thorac Cardiovasc Surg 100: 287–291
Baba M, Aikou T, Yoshinaka H, Natsugoe S, Fukumoto T, Shimazu H and Akazawa K (1994) Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus [see comments]. Ann Surg 219: 310–316
Baba M, Aikou T, Natsugoe S, Kusano C, Shimada M, Kimura S and Fukumoto T (1997) Lymph node and perinodal tissue tumor involvement in patients with esophagectomy and three-field lymphadenectomy for carcinoma of the esophagus. J Surg Oncol 64: 12–16
Bhansali MS, Fujita H, Kakegawa T, Yamana H, Ono T, Hikita S, Toh Y, Fujii T, Tou U and Shirouzu K (1997) Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 21: 275–281
Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159
Crombach G, Scharl A, Vierbuchen M, Wurz H and Bolte A (1989) Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix. Cancer 63: 1337–1342
Fahn HJ, Wang LS, Huang BS, Huang MH and Chien KY (1994) Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus. Ann Thorac Surg 57: 677–681
Glickman JN, Torres C, Wang HH, Turner JR, Shahsafaei A, Richards WG, Sugarbaker DJ and Odze RD (1999) The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 85: 769–778
Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D and Martin EW Jr (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke’s B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73: 563–569
International Union Against Cancer (1997) TNM Classification of Malignant Tumours. Wiley-Liss: New York
Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, Passlick B, Broelsch CE and Pantel K (1997) Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 337: 1188–1194
Japanese Society for Esophageal Diseases (1992) Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus. Kanehara: Tokyo
Jeffers MD, O’Dowd GM, Mulcahy H, Stagg M, O’Donoghue DP and Toner M (1994) The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 172: 183–187
Kato H (1992) Squamous cell carcinoma antigen. In: Serological Cancer Markers, Sell S (ed), pp. 437–451. Totowa: Humana
Kato H and Torigoe T (1977) Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40: 1621–1628
Kato H, Tachimori Y, Mizobuchi S, Igaki H and Ochiai A (1993) Cervical, mediastinal, and abdominal lymph node dissection (three-field dissection) for superficial carcinoma of the thoracic esophagus. Cancer 72: 2879–2882
Law SY, Fok M and Wong J (1996) Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg 83: 107–111
Luketich JD, Kassis ES, Shriver SP, Nguyen NT, Schauer PR, Weigel TL, Yousem SA and Siegfried JM (1998) Detection of micrometastases in histologically negative lymph nodes in esophageal cancer. Ann Thorac Surg 66: 1715–1718
McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC and Wright RG (1996) Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 73: 88–95
Malassagne B, Tiret E, Duprez D, Coste J, de Sigalony JP and Parc R (1997) Prognostic value of thoracic recurrent nerve nodal involvement in esophageal squamous cell carcinoma. J Am Coll Surg 185: 244–249
Maruo T, Shibata K, Kimura A, Hoshina M and Mochizuki M (1985) Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization. Cancer 56: 302–308
Matsuda H, Mori M, Tsujitani S, Ohno S, Kuwano H and Sugimachi K (1990) Immunohistochemical evaluation of squamous cell carcinoma antigen and S-100 protein-positive cells in human malignant esophageal tissues. Cancer 65: 2261–2265
Mealy K, Feely J, Reid I, McSweeney J, Walsh T and Hennessy TP (1996) Tumour marker detection in oesophageal carcinoma. Eur J Surg Oncol 22: 505–507
Morita M, Kuwano H, Ohno S, Furusawa M and Sugimachi K (1994) Characteristics and sequence of the recurrent patterns after curative esophagectomy for squamous cell carcinoma. Surgery 116: 1–7
Nakamura T, Ide H, Eguchi R, Hayashi K, Takasaki K and Watanabe S (1998) CYFRA 21–1 as a tumor marker for squamous cell carcinoma of the esophagus. Dis Esophagus 11: 35–39
Nishimaki T, Tanaka O, Suzuki T, Aizawa K, Hatakeyama K and Muto T (1994) Patterns of lymphatic spread in thoracic esophageal cancer. Cancer 74: 4–11
Pelkey TJ, Frierson HF Jr and Bruns DE (1996) Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 42: 1369–1381
Quillien V, Raoul JL, Laurent JF, Meunier B and Le Prise E (1998) Comparison of Cyfra 21–1, TPA and SCC tumor markers in esophageal squamous cell carcinoma. Oncol Rep 5: 1561–1565
Raj GV, Moreno JG and Gomella LG (1998) Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 82: 1419–1442
Roder JD, Busch R, Stein HJ, Fink U and Siewert JR (1994) Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 81: 410–413
Schneider SS, Schick C, Fish KE, Miller E, Pena JC, Treter SD, Hui SM and Silverman GA (1995) A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci USA 92: 3147–3151
Shimada Y (1999) Esophageal cancers. In: Human Cell Culture, Masters JRW and Palsson B (eds), Vol. 1, pp. 179–212. Kluwer Academic: Amsterdam
Shimada Y, Imamura M, Wagata T, Yamaguchi N and Tobe T (1992) Characterization of 21 newly established esophageal cancer cell lines [published erratum appears in Cancer 1992 70 (1): 206]. Cancer 69: 277–284
Siewert JR and Roder JD (1992) Lymphadenectomy in esophageal cancer surgery. Dis Esophagus 5: 91–97
Skinner DB, Dowlatshahi KD and DeMeester TR (1982) Potentially curable cancer of the esophagus. Cancer 50: 2571–2575
Stenman J, Lintula S, Hotakainen K, Vartiainen J, Lehvaslaiho H and Stenman UH (1997) Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix. Int J Cancer 74: 75–80
Sugimachi K, Matsuura H, Kai H, Kanematsu T, Inokuchi K and Jingu K (1986) Prognostic factors of esophageal carcinoma: univariate and multivariate analyses. J Surg Oncol 31: 108–112
Suminami Y, KF, Sekiguchi K and Kato H (1991) Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem Biophys Res Commun 181: 51–58
Takeshima N, Suminami Y, Takeda O, Abe H, Okuno N and Kato H (1992) Expression of mRNA of SCC antigen in squamous cells. Tumour Biol 13: 338–342
Ueda G, Inoue Y, Yamasaki M, Inoue M, Tanaka Y, Hiramatsu K, Saito J, Nishino T and Abe Y (1984) Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors. Int J Gynecol Pathol 3: 291–298
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Kano, M., Shimada, Y., Kaganoi, J. et al. Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA. Br J Cancer 82, 429–435 (2000). https://doi.org/10.1054/bjoc.1999.0938
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.0938
Keywords
This article is cited by
-
Pemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer
British Journal of Cancer (2010)
-
Occult tumor cells in lymph nodes as a predictor for tumor relapse in pancreatic adenocarcinoma
Langenbeck's Archives of Surgery (2008)